W

Welkom Clinical Trial Centre | Welkom, South Africa

Research site

(Unclaimed)

Location

189 Power Road, 9460,South Africa, Welkom, Free State, South Africa

Site insights

Top conditions

Top treatments

Bococizumab

JNJ-53718678

Pimodivir

Naproxen

GRT7039

Pregabalin

Tamiflu

CHF5993

Oseltamivir

MHAA4549A

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 13 total trials

A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza (ANCHOR)

The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to pla...

Active, not recruiting

Influenza

Combination Product: CD388 Injection

Combination Product: Placebo

Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. (RENOIR)

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Active, not recruiting

Lower Respiratory Tract Illness

Biological: RSVpreF

Biological: Placebo

Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma (TRECONY)

This study will compare an asthma inhaler that uses a new climate friendly alternative propellant to an asthma inhaler with an existing propellant. W...

Enrolling

Asthma

Drug: CHF5993 pMDI with HFA-134a

Drug: CHF5993 pMDI with HFA-152a